SYON CAPITAL LLC

Position in LLY — ELI LILLY & Co

CIK 1999353 SAN FRANCISCO, CA

Position in LLY

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$11,790,531

-$2,040,601 QoQ

Shares Held

12,819

-0.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.93%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SYON CAPITAL LLC holds $41,641,759 across 15 Drug Manufacturers - General names. LLY ranks #1 (28.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	12,819	$11,790,531
2	JNJ	Johnson & Johnson	29,338	$7,171,380
3	ABBV	AbbVie Inc.	25,838	$5,619,506
4	MRK	Merck & Co., Inc.	25,670	$3,087,844
5	AMGN	Amgen Inc	8,271	$2,910,151
6	GILD	Gilead Sciences, Inc.	20,745	$2,891,230
7	AZN	Astrazeneca PLC	11,958	$2,358,356
8	GSK	GSK plc	29,471	$1,626,504

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$11,790,531	12,819	-0.4%	Shares	Sole	2026-05-13
2025-12-31	$13,831,132	12,870	-2.9%	Shares	Sole	2026-02-11
2025-09-30	$10,112,039	13,253	+10.1%	Shares	Sole	2025-11-07
2025-06-30	$9,386,320	12,041	+3.2%	Shares	Sole	2025-08-14
2025-03-31	$9,638,369	11,670	+11.2%	Shares	Sole	2025-05-15
2024-12-31	$8,105,228	10,499	-6.8%	Shares	Sole	2025-02-14
2024-09-30	$9,977,456	11,262	+1.1%	Shares	Sole	2024-11-13
2024-06-30	$10,081,406	11,135	-0.1%	Shares	Sole	2024-08-13
2024-03-31	$8,674,254	11,150	+3.4%	Shares	Sole	2024-05-14
2023-12-31	$6,288,540	10,788	+13.4%	Shares	Sole	2024-02-26
2023-09-30	$5,110,254	9,514	—	Shares	Sole	2023-11-03
No filing history on record for this holder in this stock.